Koelis software fusion interface using 3D ultrasound for transperineal guidance in prostate cancer focal therapy
KOELIS announces the first interim results of the VIOLETTE trial which evaluates the use of OBT-Fusion® technology in focal ablation of the prostate by microwave needles
20 nov. 2024 09h00 HE | Koelis
GRENOBLE, France, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”, www.koelis.com), a global leader and innovator in prostate care, announced today passing an important...
Koelis Trinity
Koelis Announces Partnership and Initial Experience with DeepHealth for AI-powered Prostate MRI Interpretation and Guidance in Fusion Biopsy
20 sept. 2024 09h07 HE | Koelis
Koelis finalizes partnership with Deep Health for AI-powered prostate MRI interpretation and guidance in fusion biopsy for prostate cancer.
CLS-Logo-1.jpg
CLS Americas Targets MRI-US Fusion-Guided Focal Laser Ablation of Prostate Tumors
25 oct. 2021 07h00 HE | Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation (FLA) systems, today announced that a...